APT 2025 Committees
| Presiding Chair | Jodi Goodwin, Takeda |
| Presiding Chair-Elect | Darcey Clark, Merck |
Discovery
| Chair | Jodi Goodwin, Takeda |
| Chair-Elect | Darcey Clark, Merck |
|
Jonathan Heyen, Treeline Bio Prathap Kumar Mahalingaiah, AstraZeneca Jon Maher, Pliant Therapeutics Rama Pai, Merck Yoav Timsit, Novartis Connie Wu, Genentech Helen Yu, Vertex |
Development
| Chair | Betty Pettersen, Alexion |
| Chair-Elect | Yuan Lu, CinRx Pharma |
|
Surekha Akella, AbbVie Joe Cichocki, Vertex Ed Dere, Genentech Birgit Fogal, Boehringer Ingelheim Pia Kasperkovitz, Bright Peak Therapeutics Heather Kowalski, BlueRock Therapeutics Christine Mollica, Amgen Daniella Pizarro, Merck Michael Santostefano, Merck Radha Sura, Gilead Nardos Tassew, The Janssen Pharmaceutical Companies of Johnson & Johnson |